8:15am ET
Health and Healthcare
Major Biotechs Have Short Sellers on the Run
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 5:25pm ET
AMGN Coverage
Page 188:20am ET
Health and Healthcare
Short Sellers Up the Ante in Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most…
7:05am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
11:50am ET
Health and Healthcare
Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
8:45am ET
Health and Healthcare
Why Have Short Sellers Backed Off Major Biotechs?
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Ally, Amgen, AT&T, BP, Chesapeake Energy, Expedia, NOV, Square, Synchrony, Twitter and More
The top analyst upgrades, downgrades and other research calls from Monday includes Ally Financial, Amgen, AT&T, BP, Chesapeake Energy, Expedia, National Oilwell Varco, Square, Synchrony and Twitter.
7:10am ET
Health and Healthcare
Major Biotechs See a Rising Tide of Short Interest
The July 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
10:25am ET
Health and Healthcare
Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
8:21am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
9:00am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
10:54am ET
Health and Healthcare
Short Sellers Up the Ante For Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest moves in…
10:30am ET
Health and Healthcare
Biotech and Pharmaceutical Giants Go All In With Big Data Analytics
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the…
9:40am ET
Health and Healthcare
Short Interest Remains Mixed in Major Biotechs
The May 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
11:40am ET
Health and Healthcare
Amgen Wins Another FDA Approval
Amgen shares made a slight gain on Tuesday after it was announced that the FDA approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture.
Chris Lange 8:00am ET
Health and Healthcare
Amgen’s Novel Migraine Treatment Gets Key Approval
Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults.
